Heterocyclic compound and pharmaceutical composition comprising same

The present invention relates to a novel heterocyclic compound capable of suppressing activity of cyclin-dependent kinase (CDK) and a pharmaceutical composition comprising the same as an active ingredient. The heterocyclic compound according to the present invention and a pharmaceutically acceptable salt thereof can be effectively used in treatment or prevention of cancers, degenerative brain diseases, etc.